Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31049855 | 1.00 | HIF1A (0.53) | HIF1ATSHRMAPTABCC4FAAH | |
| SCHEMBL17696302 | 1.00 | HIF1A (0.53) | HIF1ATSHRMAPTABCC4FAAH | |
| SCHEMBL515887 | 1.00 | — | — | |
| SCHEMBL7522844 | 1.00 | HIF1A (0.53) | HIF1ATSHRMAPTABCC4FAAH | |
| SCHEMBL5336674 | 1.00 | HIF1A (0.53) | HIF1ATSHRMAPTABCC4FAAH | |
| SCHEMBL107549 | 1.00 | HIF1A (0.53) | HIF1ATSHRMAPTABCC4FAAH | |
| SCHEMBL24287754 | 1.00 | HIF1A (0.53) | HIF1ATSHRMAPTABCC4FAAH | |
| SCHEMBL9246360 | 1.00 | HIF1A (0.53) | HIF1ATSHRMAPTABCC4FAAH | |
| SCHEMBL455320 | 1.00 | HIF1A (0.53) | HIF1ATSHRMAPTABCC4FAAH | |
| SCHEMBL31049873 | 1.00 | HIF1A (0.53) | HIF1ATSHRMAPTABCC4FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2980060-B1 | METHOD FOR PRODUCING DIALDEHYDE | KURARAY CO (JP) | 2020-10-28 | — | — | EP | claimed |
| CN-105050996-B | The manufacturing method of dialdehyde | 株式会社可乐丽 | 2018-05-29 | — | — | CN | claimed |
| US-9464018-B2 | Method for producing dialdehyde | KURARAY CO., LTD. (JP) | 2016-10-11 | — | — | US | claimed |
| US-20160052852-A1 | METHOD FOR PRODUCING DIALDEHYDE | KURARAY CO., LTD. (JP) | 2016-02-25 | — | — | US | claimed |
| EP-2980060-A1 | METHOD FOR PRODUCING DIALDEHYDE | Kuraray Co., Ltd. (JP) | 2016-02-03 | — | — | EP | claimed |
| CN-105050996-A | Method for producing dialdehyde | KURARAY CO | 2015-11-11 | — | — | CN | claimed |
| US-8268772-B2 | Depot preparations | SYMRISE AG (DE) | 2012-09-18 | — | — | US | claimed |
| EP-1677749-B1 | SHORT-CHAIN ENOL ESTERS AS ODIFEROUS SUBSTANCE PRECURSORS | SYMRISE GMBH & CO KG (DE) | 2010-05-05 | — | — | EP | claimed |
| CN-122094561-A | Liquid fertilizer ready-to-use agrochemical formulation | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122094649-A | Personal care compositions | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260125550-A1 | COMPOSITION, DISPERSING AGENT FOR SUSPENSION POLYMERIZATION, AND METHOD FOR PRODUCING VINYL-BASED POLYMER | KURARAY CO., LTD. (JP) | 2026-05-07 | — | — | US | disclosed |
| US-20250361250-A1 | FLUORINE-CONTAINING SILANE COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-11-27 | — | — | US | disclosed |
| EP-4600301-A1 | COMPOSITION, DISPERSING AGENT FOR SUSPENSION POLYMERIZATION, AND METHOD FOR PRODUCING VINYL-BASED POLYMER | Kuraray Co., Ltd. (JP) | 2025-08-13 | — | — | EP | disclosed |
| CN-119998390-A | Composition, dispersant for suspension polymerization, and method for producing vinyl polymer | 株式会社可乐丽 | 2025-05-13 | — | — | CN | disclosed |
| US-20030083376-A1 | Depot preparations | SYMRISE GMBH & CO. KG (DE) | 2003-05-01 | — | — | US | disclosed |
| US-20020156207-A1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2002-10-24 | — | — | US | disclosed |
| CN-1342715-A | Polar group-containing olefin copolymer, process for producing the same, thermoplastic resin composition containing the same, and use thereof | MITSUI CHEMICALS INC (JP) | 2002-04-03 | — | — | CN | disclosed |
| EP-1186619-A2 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition contaning the copolymer, and uses thereof | Mitsui Chemicals, Inc. (JP) | 2002-03-13 | — | — | EP | disclosed |
| CN-1328596-A | Liquid crystal compound | ROLIC AG (CH) | 2001-12-26 | — | — | CN | disclosed |
| US-5105005-A | Organoleptic | HAARMANN & REIMER GMBH (DE) | 1992-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125550-A1 | COMPOSITION, DISPERSING AGENT FOR SUSPENSION POLYMERIZATION, AND METHOD FOR PRODUCING VINYL-BASED POLYMER | VCL, VCAM1, ADH1A | HIF1A 3312/4885TSHR 4763/4885MAPT 308/4885 |
| US-20030083376-A1 | Depot preparations | FABP4, ADH1C, LIPE | HIF1A 2559/4885TSHR 1109/4885MAPT 1020/4885 |
| US-20160052852-A1 | METHOD FOR PRODUCING DIALDEHYDE | ENO1, ALDH1A2, DERA | HIF1A 813/4885TSHR 1356/4885MAPT 4752/4885 |
| US-20250361250-A1 | FLUORINE-CONTAINING SILANE COMPOUND | FLI1, AFF1, RFT1 | HIF1A 619/4885TSHR 2035/4885MAPT 4711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.